Who invested in Autolomous

3 rounds we have observed, with the one investor named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$11Mraised across 3 rounds since 2022, from 3 sources

$1.8MRound$5.2MRound$4.4MRound

Latest round: Round, $4.4MMar 2025
Biggest round: $5.2MRound · Sept 2024
Investors: 1

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

202320242025

$1.8MRound$5.2MRound$4.4MRound

First round: Round, $1.8M
Biggest round: $5.2M
Usual gap between rounds: 21 months

The rounds

Mar 2025
Round$4.4M1 new
- Innovate UK
Source recorded
Sept 2024
Round$5.2M
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
Dec 2022
Round$1.8M
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet

Funding filed with regulators

Autolomous filed 2 raises, $7.0M in all. Filings say how much was sold and to how many investors; they never name the investors.

Sept 2024$5.2MUK share allotment
Dec 2022$1.8MUK share allotment

Founders and team

From Autolomous's own website: 2 founders, 1 on the team.

Alexander SeyfCo-founder & CEO

Alexis BlainCo-founder & CTO

Walid FahmeCOO

Everyone who backed them

Innovate UKVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Autolomous as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.